Clinical trials
Phase 1/2 Cholangiocarcinoma trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 4 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tango Therapeutics, Inc. | 2 |
| Alentis Therapeutics AG | 1 |
| Amgen | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Celgene | 1 |
| Elevar Therapeutics | 1 |
| Forma Therapeutics, Inc. | 1 |
| Genoscience Pharma | 1 |
| Taiho Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 10 |
| Carcinoma, Hepatocellular | 2 |
| Glioblastoma | 2 |
| Mesothelioma | 2 |
| Neurofibrosarcoma | 2 |
| Sarcoma | 2 |
| Adenocarcinoma of Lung | 1 |
| Bile Duct Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.